🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Therapy related acute myeloid leukemia and myelodysplasia (t-MN) is a poten...
Status
Recruiting
Location
Istituto Europeo di Oncologia
Start Date
2020-10-02
Trial ID
NCT06785077
Treatments Being Tested
Prior to Amendment #7: The hypothesis of this study is that the combination...
Status
Terminated
Location
Washington University School of Medicine
Start Date
2020-11-19
Trial ID
NCT04331067
Treatments Being Tested
In this study the investigators will incorporate a wide range of clinical v...
Status
Recruiting
Location
Washington University School of Medicine
Start Date
2016-03-10
Trial ID
NCT02604563
Treatments Being Tested
This phase II trial compares shorter-duration versus longer-duration mainte...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2023-07-17
Trial ID
NCT05898646
This phase I trial tests the safety and side effects of pacritinib in combi...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2026-10-01
Trial ID
NCT06675123
This study will evaluate the response and long-term effects of alpha-interf...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
1995-05-05
Trial ID
NCT00001379
HEMATO-BIO-IPC-2013-015 is a monocenter prospective longitudinal study. Our...
Status
Completed
Location
Institut Paoli-Calmettes
Start Date
2014-05
Trial ID
NCT02320656
Treatments Being Tested
This phase III trial compares the effect of high dose chemotherapy and the ...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2025-01-30
Trial ID
NCT06724237
This phase II trial studies fluorothymidine F 18 (FLT) positron emission to...
Status
Active Not Recruiting
Location
Mayo Clinic in Rochester
Start Date
2016-04-20
Trial ID
NCT02392429
As T-cell receptor sequencing by LymphoTrack is an assay with high sensitiv...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2017-07-31
Trial ID
NCT03297697
Treatments Being Tested